| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ionis Pharmaceuticals, Inc. (IONS) has 21 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. IONS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 260.3K | $19.78M | - | |
| Dir | 164.0K | $12.47M | -8,000 | |
| VP | 100.3K | $7.62M | - | |
| VP | 83.3K | $6.33M | -60,846 | |
| CFO | 82.7K | $6.28M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 2025 | Devers Shannon L. | EVP, Chief Human Resources Ofc | Sale+OE | 7,263 | $73.06 | $530,637.50 | -17.8% | +7.9% | - | |
| Oct 15, 2025 | Parshall B Lynne74 | Director | Sell | 5,000 | $71.74 | $358,721.50 | -7.5% | +9.8% | - | |
| Oct 15, 2025 | Birchler Brian52 | EVP, Corp And Development Ops | Sale+OE | 23,900 | $72.13 | $1,723,987.11 | -17.4% | +9.8% | - | |
| Oct 6, 2025 | Swayze Eric63 | EVP Research | Sell | 6,849 | $69.02 | $472,717.98 | -18.4% | +13.8% | - | |
| Oct 6, 2025 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sale+OE | 13,441 | $69.74 | $937,337.63 | -10.8% | +13.8% | - | |
| Oct 6, 2025 | Monia Brett P60 | Chief Executive Officer | Sell | 437 | $69.26 | $30,268.24 | -0.2% | +13.8% | - | |
| Oct 6, 2025 | Baroldi Joseph52 | EVP, Chief Business Officer | Sell | 1,625 | $69.37 | $112,725.11 | -5.1% | +13.8% | - | |
| Oct 2, 2025 | O'Neil Patrick R.57 | EVP CLO &General Counsel | Sale+OE | 64,664 | $67.69 | $4,377,054.43 | -36.1% | +15.7% | - | |
| Oct 2, 2025 | Baroldi Joseph52 | EVP, Chief Business Officer | Sale+OE | 15,000 | $68.01 | $1,020,210.00 | -32.0% | +15.7% | - | |
| Oct 2, 2025 | Swayze Eric63 | EVP Research | Sale+OE | 27,114 | $66.16 | $1,793,744.13 | -26.7% | +15.7% | - |